skip to main content
Idioma:
Mostrar Somente
Refinado por: Base de dados/Biblioteca: HighWire Press (Free Journals) remover assunto: Pharmacology. Drug Treatments remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Dexmedetomidine reduces seizure threshold during enflurane anaesthesia in cats
Dexmedetomidine reduces seizure threshold during enflurane anaesthesia in cats
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dexmedetomidine reduces seizure threshold during enflurane anaesthesia in cats

Miyazaki, Y ; Adachi, T ; Kurata, J ; Utsumi, J ; Shichino, T ; Segawa, H

British journal of anaesthesia : BJA, 1999-06, Vol.82 (6), p.935-937 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Effects of propofol on lactate accumulation and oedema formation in focal cerebral ischaemia in hyperglycaemic rats
Effects of propofol on lactate accumulation and oedema formation in focal cerebral ischaemia in hyperglycaemic rats
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of propofol on lactate accumulation and oedema formation in focal cerebral ischaemia in hyperglycaemic rats

Ishii, H. ; Arai, T. ; Segawa, H. ; Morikawa, S. ; Inubushi, T. ; Fukuda, K.

British journal of anaesthesia : BJA, 2002-03, Vol.88 (3), p.412-417 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Effects of xenon on acetylcholine release in the rat cerebral cortex in vivo
Effects of xenon on acetylcholine release in the rat cerebral cortex in vivo
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of xenon on acetylcholine release in the rat cerebral cortex in vivo

Shichino, T. ; Murakawa, M. ; Adachi, T. ; Miyazaki, Y. ; Segawa, H. ; Fukuda, K. ; Mori, K.

British journal of anaesthesia : BJA, 2002-06, Vol.88 (6), p.866-868 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate
The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate
Material Type:
Artigo 		Adicionar ao Meu Espaço

The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate

Kuroda, Junya ; Kimura, Shinya ; Segawa, Hidekazu ; Kobayashi, Yutaka ; Yoshikawa, Toshikazu ; Urasaki, Yoshimasa ; Ueda, Takanori ; Enjo, Fumio ; Tokuda, Harukuni ; Ottmann, Oliver G. ; Maekawa, Taira

Blood, 2003-09, Vol.102 (6), p.2229-2235 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
5
A Third-Generation Bisphosphonate, Minodronic Acid (YM529), Augments the Interferon α/β-Mediated Inhibition of Renal Cell Cancer Cell Growth Both In vitro and In vivo
A Third-Generation Bisphosphonate, Minodronic Acid (YM529), Augments the Interferon α/β-Mediated Inhibition of Renal Cell Cancer Cell Growth Both In vitro and In vivo
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Third-Generation Bisphosphonate, Minodronic Acid (YM529), Augments the Interferon α/β-Mediated Inhibition of Renal Cell Cancer Cell Growth Both In vitro and In vivo

YUASA, Takeshi ; NOGAWA, Masaki ; KIMURA, Shinya ; YOKOTA, Asumi ; SATO, Kiyoshi ; SEGAWA, Hidekazu ; KURODA, Junya ; MAEKAWA, Taira

Clinical cancer research, 2005-01, Vol.11 (2), p.853-859 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
6
A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy
A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy

Segawa, Y. ; Aogi, K. ; Inoue, K. ; Sano, M. ; Sekine, I. ; Tokuda, Y. ; Isobe, H. ; Ogura, T. ; Tsuboi, M. ; Atagi, S.

Annals of oncology, 2009-11, Vol.20 (11), p.1874-1880 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
7
γ-Aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism
γ-Aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism
Material Type:
Artigo 		Adicionar ao Meu Espaço

γ-Aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism

AZUMA, Haruhito ; INAMOTO, Teruo ; TAKAHARA, Kiyoshi ; KATSUOKA, Yoji ; WATANABE, Masahito ; SAKAMOTO, Takeshi ; KIYAMA, Satoshi ; UBAI, Takanobu ; SHINOHARA, Yuko ; MAEMURA, Kentaro ; TSUJI, Motomu ; SEGAWA, Naoki ; MASUDA, Hiroshi

Cancer research (Chicago, Ill.), 2003-12, Vol.63 (23), p.8090-8096 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
8
Decreased expression of early growth response-1 and its role in uterine leiomyoma growth
Decreased expression of early growth response-1 and its role in uterine leiomyoma growth
Material Type:
Artigo 		Adicionar ao Meu Espaço

Decreased expression of early growth response-1 and its role in uterine leiomyoma growth

SHOZU, Makio ; MURAKAMI, Kouichi ; SEGAWA, Tomoya ; KASAI, Tadayuki ; ISHIKAWA, Hiroshi ; SHINOHARA, Kazunori ; OKADA, Masahiko ; INOUE, Masaki

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (13), p.4677-4684 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
9
Fractionated administration of irinotecan and cisplatin for treatment of extensive-disease small-cell lung cancer: a phase II study
Fractionated administration of irinotecan and cisplatin for treatment of extensive-disease small-cell lung cancer: a phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fractionated administration of irinotecan and cisplatin for treatment of extensive-disease small-cell lung cancer: a phase II study

Takigawa, Nagio ; Fujiwara, Keiichi ; Ueoka, Hiroshi ; Kiura, Katsuyuki ; Tabata, Masahiro ; Hiraki, Akio ; Shibayama, Takuo ; Segawa, Yoshihiko ; Kamei, Haruhito ; Hiraki, Shunkichi ; Tanimoto, Mitsune ; Harada, Mine

Anticancer research, 2003-01, Vol.23 (1B), p.557 [Periódico revisado por pares]

Greece

Sem texto completo

Citações Citado por
10
Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids
Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids

Moritaka, T ; Kiura, K ; Ueoka, H ; Tabata, M ; Segawa, Y ; Shibayama, T ; Takigawa, N ; Ohnoshi, T ; Harada, M

Anticancer research, 1998-03, Vol.18 (2A), p.927 [Periódico revisado por pares]

Greece

Sem texto completo

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Mostrar Somente

  1. Recursos Online (8)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.